Advanced Filters
noise

Lund, Sweden Clinical Trials

A listing of Lund, Sweden clinical trials actively recruiting patients volunteers.

Found 180 clinical trials

Added Diagnostic Value of Point of Care Ultrasound in Acute Dyspnea

Dyspnea is a common diagnostic challenge in the Emergency Department (ED). Delay in diagnosis will increase time to correct treatment and could impact outcome. Previous studies have shown excellent diagnostic performance of point of care ultrasound (POCUS) to detect and differentiate between several important diagnosis (e.g heart failure and pneumonia) …

18 years of age All Phase N/A
S Sofie Westling, MD PhD

Aspects of Self-harm - Cognition, Imaging and Treatability

Deliberate self-harm (DSH) is a common symptom in psychiatric disorders. This study aim at increased understanding of parameters associated with DSH with the long term goal to potentially improve and possibly personalise its treatment. In short, the study will characterise cognitive, psychiatric and demographic factors with focus on executive function …

18 - 65 years of age All Phase N/A
P Petter Holmberg, PhD student

New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active Tuberculosis

Current diagnostic tools such as interferon gamma release assay (IGRA) and purified protein derivative (PPD) can not distinguish patients with latent tuberculosis infection (LTBI) and persistence of live mycobacteria. This inability to rule out living mycobacteria in patients investigated for LTBI leads to unnecessary and potentially harmful treatment regimes all …

15 - 100 years of age All Phase N/A
M Magnus Nilsson, PhD

Which Factors Are Relevant for Treatment Outcome in Dialectical Behaviour Therapy for Borderline Personality Disorder?

The objective of this project is to investigate factors that contribute to the success and lack of success in DBT among individuals with BPD and a history of self-harm in a clinical psychiatric setting. Do certain personality factors and identity disturbance predict the treatment outcome of DBT in individuals with …

18 years of age All Phase N/A
S Sandra Lindstedt Ingemansson, MD, PhD

Exhaled Breath Particles in Lung Transplantation

Lung transplantation (LTx) is the only effective treatment for patients with end stage lung disease. Of the major organs transplanted, survival following LTx is the lowest with a mean of 5 years. Despite improvements, primary graft dysfunction (PGD) remains the leading cause of early mortality and contributes to the development …

16 - 75 years of age All Phase N/A
W Wenche Melander, PhD-student

Rehabilitation and Recovery for Persons With Esophageal or Gastric Cancer

This study aims to develop and evaluate a model for systematic and evidence-based cancer rehabilitation for people with esophageal and gastric cancer to provide conditions for a better quality of life and fewer cancer-related symptoms.

18 years of age All Phase N/A
C Carl-Fredrik Rönnow, MD, PhD

Epigenetic Regulation of Colorectal Polyps and Cancer

The goal of this study is to learn about the epigenetic and genetic regulation (microRNA/mRNA) of colorectal polyps and their evolvement as polyps and to colorectal cancer. Furthermore, the study aims at investigating whether certain epigenetic features, linked to polyps and/or cancer are traceable in blood samples. The main questions …

18 years of age All Phase N/A
J Johanna Sjovall, MD, PhD

Monitoring and Early Response Evaluation Using HPV DNA - A Study on Patients With HPV-positive Throat Cancer (MER-HPV)

The goal of this clinical trial is to determine the value of circulating tumour HPV DNA (human papilloma virus DNA found in the blood) at diagnosis, during treatment, and in the follow-up of patients diagnosed and treated for throat cancer caused by HPV. The main question to answer is if …

18 years of age All Phase N/A
C Christina Siesing, M.D. PhD.

On-treatment Biomarkers in Metastatic Colorectal Cancer for Life

By virtue of an increased strategic use of cytotoxic and biological agents, and more options for locoregional treatment, the survival of patients with metastatic colorectal cancer (mCRC) has improved considerably in the past decades. The personalized approach to systemic treatment is further aided by the use of complementary molecular biomarkers. …

18 - 110 years of age All Phase N/A
M Mårten Söderberg, PhD

Reperfusion Treatment in Acute Pulmonary Embolism

International guidelines recommend immediate reperfusion with systemic thrombolysis (ST) as first-line treatment in high-risk pulmonary embolism (PE). The therapy improves hemodynamics and overall survival but is also associated with a significant risk of severe bleeding. Catheter-directed intervention (CDI) is recommended as an alternative reperfusion therapy in high-risk PE when ST …

18 years of age All Phase N/A

Simplify language using AI